Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market
Holding BEAM?
Track your performance easily

Beam Therapeutics (BEAM) Cash flow

1,279 Followers

Beam Therapeutics Cash Flow

BEAM's free cash flow for Q3 2024 was $-89.70M. For the 2024 fiscal year, BEAM's free cash flow was decreased by $-156.50M and operating cash flow was $-88.13M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -135.81M$ -149.19M$ 22.53M$ -66.27M$ -95.74M$ -72.00M
Investing Cash Flow
$ 156.83M$ 71.84M$ -461.34M$ -294.14M$ -100.12M$ -66.66M
Financing Cash Flow
$ 38.01M$ 276.45M$ 111.59M$ 756.14M$ 195.30M$ 41.28M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.27B$ 444.61M$ 245.52M$ 572.74M$ 49.99M$ 50.55M
Income Tax Paid Supplemental Data
----$ 561.00K-
Interest Paid Supplemental Data
$ 52.00K$ 160.00K$ 376.00K$ 567.00K$ 561.00K$ 187.00K
Issuance Of Capital Stock
$ 36.22M$ 273.20M$ 111.33M$ 757.45M$ 192.51M$ 37.90M
Issuance Of Debt
$ -1.12M$ -2.25M$ -2.29M$ -2.12M$ -1.57M$ 6.18M
Repayment Of Debt
$ -1.12M$ -2.25M$ -2.29M$ -2.12M$ -1.57M$ -464.00K
Free Cash Flow
$ -145.37M$ -182.93M$ -26.42M$ -113.08M$ -112.10M$ -84.52M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Beam Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis